Disposition of 35604 shares by Sharon Mates of Intracellular at 12.73 subject to Rule 16b-3

ITCI Stock  USD 85.69  0.24  0.28%   
Under 51% of Intracellular's investor base is interested to short. The analysis of overall sentiment of trading Intracellular Th stock suggests that many investors are impartial at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.
  
Filed transaction by Intracellular Th Director, Officer: Chairman And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 35604 stock option (right to buy) at 12.73 of Intracellular by Sharon Mates on 29th of August 2024. This event was filed by Intracellular Th with SEC on 2024-08-29. Statement of changes in beneficial ownership - SEC Form 4. Sharon Mates currently serves as co-founder, chairman, ceo and pres of Intracellular Th

Cash Flow Correlation

Intracellular's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Intracellular's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Intracellular Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Intracellular Th Historical Investor Sentiment

Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Intracellular news discussions. The higher the estimate score, the more favorable the investor's outlook on Intracellular.

Intracellular Fundamental Analysis

We analyze Intracellular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

Intracellular is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Intracellular Th Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intracellular stock to make a market-neutral strategy. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics with similar companies.

Peers

Intracellular Related Equities

CYTHCyclo Therapeutics   4.29   
0%
100.0%
ALKSAlkermes Plc   3.90   
0%
90.0%
IRWDIronwood Pharmaceuticals   2.99   
0%
69.0%
AMPHAmphastar   2.04   
0%
47.0%
ANIPANI Pharmaceuticals   1.88   
0%
43.0%
AQSTAquestive Therapeutics   1.11   
0%
25.0%
PCRXPacira BioSciences,   0.98   
0%
22.0%
AMRXAmneal Pharmaceuticals,   0.84   
0%
19.0%
NBIXNeurocrine Biosciences   0.52   
0%
12.0%
DVAXDynavax Technologies   0.49   
0%
11.0%
COLLCollegium Pharmaceutical   1.48   
34.0%
0%

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories